Lilly’s Olumiant, spurned by FDA, gets nod from NICE
Lilly’s Olumiant, spurned by FDA, gets nod from NICE Eli Lilly has won a nod from NICE for its anticipated blockbuster and Humira competitor, Olumiant, a modicum of good news […]
Lilly’s Olumiant, spurned by FDA, gets nod from NICE Eli Lilly has won a nod from NICE for its anticipated blockbuster and Humira competitor, Olumiant, a modicum of good news […]
More consumer woes for Bayer drag down sales, earnings forecasts On Friday, Bayer announced it would be lowering its earnings forecasts with its second-quarter earnings release—and that consumer health was, […]
Alkermes says it’s advancing ‘full steam’ with schizophrenia candidate Alkermes has cleared the first major hurdle in its bid to advance schizophrenia candidate ALKS 3831, showing an improvement over placebo […]
Cara tanks after oral pain drug misses mark in phase 2b A phase 2b trial of Cara Therapeutics’ CR845 has missed its primary endpoint. An oral formulation of the kappa […]
Unbowed by Mylan election, mutinous investors renew calls for Coury’s exit Even after Mylan’s investors re-elected the drugmaker’s entire board last week, some aren’t giving up on their demands for […]
IRS investigates patient charity as a possible ‘conduit’ for Big Pharma sales Federal tax investigators have set their sights on patient assistance charity Chronic Disease Fund, which now goes by […]
Atlas rolls out its XI biotech fund, with 0M up for grabs Cambridge venture capital firm Atlas Venture has raised its 11th fund, totaling $350 million, as it looks to […]
Coherus slashes staff by a third after Amgen biosimilar knockback The FDA’s rejection of Coherus BioSciences’ biosimilar version of Amgen’s Neulasta means that 51 people at the company will lose […]
Before Iclusig safety flaws went public, ex-Ariad staffer told family to sell shares: feds Two former Ariad employees and one spouse of a former employee are in hot water for […]
As Congress battles over healthcare, Johnson & Johnson CEO says real reform will take time—and cooperation While Republican senators work feverishly on a healthcare bill, one prominent pharma CEO says […]